Malaria Diagnostics Market Report by Technology (Microscopy, Rapid Diagnostic Tests (RDTs), Molecular Diagnostic Tests), End Use (Hospital, Clinics, Diagnostic Centers), and Region 2025-2033

Malaria Diagnostics Market Report by Technology (Microscopy, Rapid Diagnostic Tests (RDTs), Molecular Diagnostic Tests), End Use (Hospital, Clinics, Diagnostic Centers), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A3896

Market Overview:

The global malaria diagnostics market size reached USD 876.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,415.9 Million by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033.

Report Attribute
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024 USD 876.6 Million
Market Forecast in 2033 USD 1,415.9 Million
Market Growth Rate (2025-2033) 5.47%


Malaria diagnostics refers to the clinical tests conducted to detect the presence of the infection in individuals. Malaria is caused by the bite of an infected female Anopheles mosquito, which leads to the transfer of Plasmodium parasites into the body. Some common symptoms include fever, fatigue, nausea and headaches. The infection is diagnosed through various rapid diagnostics, microscopy and molecular diagnostic tests. These tests use antigen detection and serology techniques using indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA). They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

Malaria Diagnostics Market Trends:

The increasing prevalence of malaria across the globe is one of the key factors creating a positive outlook for the market. Malaria is a life-threatening infection that has caused a significant loss of human lives, especially in developing nations. However, rising awareness among the masses regarding the available diagnostic and treatment alternatives for malaria is providing a thrust to the market growth. Healthcare centers and diagnostic laboratories are widely adopting microscopic diagnostics to identify the parasite at different stages and design suitable treatment plans. Additionally, various technological advancements, such as the development of the Quantitative Buffy Coat (QBC) method and peripheral blood smear technique for diagnosing malaria, are acting as other growth-inducing factors. In line with this, the availability of Point-of-Care (POC) diagnostic devices for enhanced accuracy is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global malaria diagnostics market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on technology and end use.

Breakup by Technology:

  • Microscopy
  • Rapid Diagnostic Tests (RDTs)
  • Molecular Diagnostic Tests
    • Conventional PCR
    • Real-Time PCR (qPCR)
       

Breakup by End Use:

  • Hospital 
  • Clinics
  • Diagnostic Centers
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Technology, End Use, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific Inc
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global malaria diagnostics market was valued at USD 876.6 Million in 2024.

We expect the global malaria diagnostics market to exhibit a CAGR of 5.47% during 2025-2033.

The rising adoption of microscopy and molecular diagnostic tests that generally use antigen detection and serology techniques to detect the presence of malaria is primarily driving the global malaria diagnostics market.

The sudden outbreak of the COVID-19 pandemic had led to the growing focus on the diagnosis and treatment of the coronavirus infection, thereby negatively impacting the global market for malaria diagnostics.

Based on the technology, the global malaria diagnostics market has been segregated into microscopy, Rapid Diagnostic Tests (RDTs), and molecular diagnostic tests. Among these, microscopy currently exhibits a clear dominance in the market.

Based on the end use, the global malaria diagnostics market can be bifurcated into hospital, clinics, and diagnostic centers. Currently, clinics hold the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Middle East and Africa currently dominates the global market.

Some of the major players in the global malaria diagnostics market include Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation, and Thermo Fisher Scientific Inc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Malaria Diagnostics Market Report by Technology (Microscopy, Rapid Diagnostic Tests (RDTs), Molecular Diagnostic Tests), End Use (Hospital, Clinics, Diagnostic Centers), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials